The three individuals joining the Sonendo team are: Jacqueline Collins, Vice President, General Counsel; Jane Metcalf, Vice President of Regulatory Affairs & Quality Assurance; and Sara Wissmueller, Vice President of Information Technology.
Jacqueline Collins spent 15 years as Vice President, General Counsel at Nobel Biocare North America, a Danaher subsidiary, and a leading dental implant and digital dentistry medical manufacturer. Jacqueline holds a BA in Political Science from the University of Oregon, an MA in Political Science from Rutgers University's Eagleton Institute, and a JD from the University of Oregon School of Law.
Jane Metcalf brings nearly 28 years of experience in Regulatory Affairs and Quality Assurance in the medical device field. Before joining Sonendo, Jane was Vice President of Regulatory Affairs for Reverse Medical Corporation, a developer and manufacturer of neurological medical devices. She has held Quality and Regulatory Vice-Presidential positions at GE HealthCare and Conmed Corporation. Jane holds a BS in Chemical Engineering from the University of Massachusetts at Amherst and an MBA from The University of California at Irvine.
Sara Wissmueller has over 25 years of Information Technology experience in various industries. Before joining Sonendo, Sara was VP of IT for Verizon Connect (Telogis), an industry leader in telematics and fleet management. Sara has managed IT departments at DB Schenker, Washington Mutual, and Tricon Global Restaurants. Sara holds a Bachelor of Business Administration from the University of Wisconsin in Management Information Systems & Accounting and a Master of Business Administration from Marquette University.
President and CEO, Bjarne Bergheim notes, "We are thrilled to add these three talented executives to our leadership team. Jackie, Jane, and Sara will be critical players as we continue to build out the Sonendo opportunity and prepare the Company for future growth."
Sonendo, Inc. is a privately-held company developing disruptive technology to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System shows significant improvements in clinical efficacy and procedure efficiency when compared to standard root canal treatment.1,2,3
1. Sigurdsson A et al. (2016) J Endod. 42:1040-48.
2. Molina B et al. (2015) J Endod. 41:1701-05.
3. Trope M et al. (1999) J Endod. 25:345–50.
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.